AdvaMed, Dems, Public Citizen Share Opposition To Proposed Labeling Rule
This article was originally published in The Gray Sheet
Executive Summary
AdvaMed is siding with Congress and consumer protection groups against a proposed FDA rule governing when a manufacturer can make a labeling change without prior approval from FDA, but the device industry has its own reasons